Skip to main content
Erschienen in: European Journal of Nutrition 6/2011

01.09.2011 | Original Contribution

Lymphatic absorption of choline plasmalogen is much higher than that of ethanolamine plasmalogen in rats

verfasst von: Megumi Nishimukai, Maya Yamashita, Yudai Watanabe, Yuya Yamazaki, Toru Nezu, Ryouta Maeba, Hiroshi Hara

Erschienen in: European Journal of Nutrition | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Plasmalogen is a subclass of phospholipids widely distributed in animal tissues and ingested as food; however, the absorptive characteristics of different classes of plasmalogen have not been clarified.

Aim of study

Our object was to compare the lymphatic output of choline and ethanolamine plasmalogens after an administration of phospholipid preparations containing each class of plasmalogens, and to analyze molecular species of plasmalogen absorbed into the lymph.

Methods

A duodenal infusion of 1 ml of 10% emulsion of choline phospholipid (PC) containing 50.6% choline plasmalogen (PlsCho) or ethanolamine phospholipid (PE) containing 52.5% ethanolamine plasmalogen (PlsEtn) was administered in the lymph duct-cannulated rats. Molecular species of plasmalogen absorbed into the lymph were measured by LC-MS/MS.

Results

Lymph outputs of PlsCho and PlsEtn increased and reached a peak value at 3 h after PC and PE injection, respectively. The peak value of PlsCho was much higher and remained at a high level until 8 h, whereas PlsEtn output fell to half of the peak value at 7 h. Total lymphatic output of PlsCho was 5-times higher than that of PlsEtn. Compositions of sn-1 in lymph plasmalogens roughly reflected those of the injected lipids, whereas sn-2 in both PlsCho and PlsEtn was rich in arachidonic acid (20:4) regardless of the composition of the administered fatty acid. Both plasmalogen and lysoplasmalogen after PE injection were not released into the portal vein.

Conclusion

Lymphatic absorption of PlsCho is much higher than that of PlsEtn in rats, and plasmalogens are re-esterified as 20:4-rich forms in the small intestine
Literatur
1.
Zurück zum Zitat Maeba R, Hara H, Ishikawa H, Hayashi S, Yoshimura N, Kusano J, Takeoka Y, Yasuda D, Okazaki T, Kinoshita M, Teramoto T (2008) Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome. J Nutr Sci Vitaminol (Tokyo) 54:196–202CrossRef Maeba R, Hara H, Ishikawa H, Hayashi S, Yoshimura N, Kusano J, Takeoka Y, Yasuda D, Okazaki T, Kinoshita M, Teramoto T (2008) Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome. J Nutr Sci Vitaminol (Tokyo) 54:196–202CrossRef
2.
Zurück zum Zitat Blank ML, Cress EA, Smith ZL, Snyder F (1992) Meats and fish consumed in the American diet contain substantial amounts of ether-linked phospholipids. J Nutr 122:1656–1661 Blank ML, Cress EA, Smith ZL, Snyder F (1992) Meats and fish consumed in the American diet contain substantial amounts of ether-linked phospholipids. J Nutr 122:1656–1661
3.
Zurück zum Zitat Nagan N, Zoeller RA (2001) Plasmalogens: biosynthesis and functions. Prog Lipid Res 40:199–229CrossRef Nagan N, Zoeller RA (2001) Plasmalogens: biosynthesis and functions. Prog Lipid Res 40:199–229CrossRef
4.
Zurück zum Zitat Lohner K (1996) Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes? Chem Phys Lipids 81:167–184CrossRef Lohner K (1996) Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes? Chem Phys Lipids 81:167–184CrossRef
5.
Zurück zum Zitat Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871–1875CrossRef Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871–1875CrossRef
6.
Zurück zum Zitat Zommara M, Tachibana N, Mitsui K et al (1995) Inhibitory effect of ethanolamine plasmalogen on iron- and copper-dependent lipid peroxidation. Free Radic Biol Med 18:599–602CrossRef Zommara M, Tachibana N, Mitsui K et al (1995) Inhibitory effect of ethanolamine plasmalogen on iron- and copper-dependent lipid peroxidation. Free Radic Biol Med 18:599–602CrossRef
7.
Zurück zum Zitat Maeba R, Ueta N (2003) Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers. J Lipid Res 44:164–171CrossRef Maeba R, Ueta N (2003) Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers. J Lipid Res 44:164–171CrossRef
8.
Zurück zum Zitat Engelmann B (2004) Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans 32:147–150CrossRef Engelmann B (2004) Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans 32:147–150CrossRef
9.
Zurück zum Zitat Hahnel D, Huber T, Kurze V, Beyer K, Engelmann B (1999) Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids. Biochem J 340:377–383CrossRef Hahnel D, Huber T, Kurze V, Beyer K, Engelmann B (1999) Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids. Biochem J 340:377–383CrossRef
10.
Zurück zum Zitat Farooqui AA, Rapoport SI, Horrocks LA (1997) Membrane phospholipid alterations in Alzheimer’s disease: deficiency of ethanolamine plasmalogens. Neurochem Res 22:523–527CrossRef Farooqui AA, Rapoport SI, Horrocks LA (1997) Membrane phospholipid alterations in Alzheimer’s disease: deficiency of ethanolamine plasmalogens. Neurochem Res 22:523–527CrossRef
11.
Zurück zum Zitat Goodenowe DB, Cook LL, Liu J, Lu Y, Jayasinghe DA, Ahiahonu PW, Heath D, Yamazaki Y, Flax J, Krenitsky KF, Sparks DL, Lerner A, Friedland RP, Kudo T, Kamino K, Morihara T, Takeda M, Wood PL (2007) Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer’s disease and dementia. J Lipid Res 48:2485–2498CrossRef Goodenowe DB, Cook LL, Liu J, Lu Y, Jayasinghe DA, Ahiahonu PW, Heath D, Yamazaki Y, Flax J, Krenitsky KF, Sparks DL, Lerner A, Friedland RP, Kudo T, Kamino K, Morihara T, Takeda M, Wood PL (2007) Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer’s disease and dementia. J Lipid Res 48:2485–2498CrossRef
12.
Zurück zum Zitat Hara H, Wakisaka T, Aoyama Y (2003) Lymphatic absorption of plasmalogen in rats. Br J Nutr 90:29–32CrossRef Hara H, Wakisaka T, Aoyama Y (2003) Lymphatic absorption of plasmalogen in rats. Br J Nutr 90:29–32CrossRef
13.
Zurück zum Zitat Nishimukai M, Wakisaka T, Hara H (2003) Ingestion of plasmalogen markedly increased plasmalogen levels of blood plasma in rats. Lipids 38:1227–1235CrossRef Nishimukai M, Wakisaka T, Hara H (2003) Ingestion of plasmalogen markedly increased plasmalogen levels of blood plasma in rats. Lipids 38:1227–1235CrossRef
14.
Zurück zum Zitat Nishimukai M, Hara H (2004) Enteral administration of soybean phosphatidylcholine enhances the lymphatic absorption of lycopene, but reduces that of alpha-tocopherol in rats. J Nutr 134:1862–1866 Nishimukai M, Hara H (2004) Enteral administration of soybean phosphatidylcholine enhances the lymphatic absorption of lycopene, but reduces that of alpha-tocopherol in rats. J Nutr 134:1862–1866
15.
Zurück zum Zitat Zemski Berry KA, Murphy RC (2004) Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J Am Soc Mass Spectrom 15:1499–1508CrossRef Zemski Berry KA, Murphy RC (2004) Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J Am Soc Mass Spectrom 15:1499–1508CrossRef
16.
Zurück zum Zitat Murphy EJ, Stephens R, Jurkowitz-Alexander M, Horrocks LA (1993) Acidic hydrolysis of plasmalogens followed by high-performance liquid chromatography. Lipids 28:565–568CrossRef Murphy EJ, Stephens R, Jurkowitz-Alexander M, Horrocks LA (1993) Acidic hydrolysis of plasmalogens followed by high-performance liquid chromatography. Lipids 28:565–568CrossRef
17.
Zurück zum Zitat Bartlett GR (1959) Colorimetric assay methods for free and phosphorylated glyceric acids. J Biol Chem 234:469–471 Bartlett GR (1959) Colorimetric assay methods for free and phosphorylated glyceric acids. J Biol Chem 234:469–471
18.
Zurück zum Zitat Ikeda I, Imaizumi K, Sugano M (1987) Absorption and transport of base moieties of phosphatidylcholine and phosphatidylethanolamine in rats. Biochim Biophys Acta 921:245–253 Ikeda I, Imaizumi K, Sugano M (1987) Absorption and transport of base moieties of phosphatidylcholine and phosphatidylethanolamine in rats. Biochim Biophys Acta 921:245–253
19.
Zurück zum Zitat Ford DA, Gross RW (1989) Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation. Proc Natl Acad Sci USA 86:3479–3483CrossRef Ford DA, Gross RW (1989) Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation. Proc Natl Acad Sci USA 86:3479–3483CrossRef
20.
Zurück zum Zitat Scott TW, Ashes JR, Fleck E, Gulati SK (1993) Effect of fish oil supplementation on the composition of molecular species of choline and ethanolamine glycerophospholipids in ruminant muscle. J Lipid Res 34:827–835 Scott TW, Ashes JR, Fleck E, Gulati SK (1993) Effect of fish oil supplementation on the composition of molecular species of choline and ethanolamine glycerophospholipids in ruminant muscle. J Lipid Res 34:827–835
21.
Zurück zum Zitat Newman RE, Bryden WL, Fleck E, Ashes JR, Storlien LH, Downing JA (2002) Dietary n-3 and n-6 fatty acids alter avian metabolism: molecular-species composition of breast-muscle phospholipids. Br J Nutr 88:19–28CrossRef Newman RE, Bryden WL, Fleck E, Ashes JR, Storlien LH, Downing JA (2002) Dietary n-3 and n-6 fatty acids alter avian metabolism: molecular-species composition of breast-muscle phospholipids. Br J Nutr 88:19–28CrossRef
Metadaten
Titel
Lymphatic absorption of choline plasmalogen is much higher than that of ethanolamine plasmalogen in rats
verfasst von
Megumi Nishimukai
Maya Yamashita
Yudai Watanabe
Yuya Yamazaki
Toru Nezu
Ryouta Maeba
Hiroshi Hara
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
European Journal of Nutrition / Ausgabe 6/2011
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-010-0149-0

Weitere Artikel der Ausgabe 6/2011

European Journal of Nutrition 6/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.